CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Cushman & Wakefield Report Highlights Uptick in Boston Life Sciences Demand and Strong Leasing Volume in 2025

Elise Maguire Ferrara • 9/4/2025
09.2024-life-sciences-update_hero.jpg

BOSTON – SEPTEMBER 4, 2025 – Cushman & Wakefield, a global real estate services firm, released its Boston BioBeat Mid-Year 2025 report, which reveals a notable rebound in demand across Greater Boston’s life sciences market. Despite record-high vacancy levels, leasing activity surged in the first half of 2025, underscoring the sector’s resilience in the face of continued economic and market headwinds. 

At mid-year, leasing volume had already reached 95.6% of 2024’s year-end total, encompassing deals of all sizes. This volume was bolstered by the market’s first new lease of more than 500,000 square feet in more than three years – BioGen’s 585,000-square-foot headquarters commitment at 75 Broadway in Cambridge. With BioGen and another lease deal, Cambridge led transaction volume in the first quarter, however the Route 128 Belt captured over 40% of leasing activity in the Q2, showcasing the breadth of demand beyond the core submarkets. 

“While supply and demand remain imbalanced in Boston’s life science market, there were notable green shoots that emerged during the first half of 2025,” said Riley McMullan, Senior Research Manager at Cushman & Wakefield. “Leasing velocity is accelerating, with larger tenants committing to long-term space in both Cambridge and suburban clusters. This renewed activity highlights the region’s enduring position as the nation’s premier hub for life sciences innovation.” 

The report also notes that while overall market vacancy rose to 33.9%, pricing remained stable, with average asking rents ticking up modestly in the second quarter. East Cambridge continued to command the highest rates, maintaining a nearly 16% premium over the market average. 

Cushman & Wakefield’s findings suggest that with a shrinking construction pipeline and robust tenant concessions, the Boston life sciences market is positioned for improved equilibrium in the coming years. 

Read the full Boston BioBeat Mid-Year 2025 report.

About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In 2024, the firm reported revenue of $9.4 billion across its core service lines of Services, Leasing, Capital markets, and Valuation and other. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture.  For additional information, visit www.cushmanwakefield.com.

CAN'T FIND WHAT YOU'RE LOOKING FOR?

Get in touch with one of our professionals.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on  Cookies

More Options
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS